Date: March 17, 2017 Dear all, Please be advised that we have legally changed our organization name. Old Name: Cancer Society of America, Inc. New Name: USA Cancer Foundation, Inc. Regards, USA Cancer Foundation, Inc.
U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in a subset of hard-to-treat tumors. The Food and Drug Administration cleared the drug, Rubraca, from Clovis Oncology Inc. for women in advanced stages of the disease who have already tried at least … Continue reading “New Ovarian Cancer Drug Wins Speedy FDA Approval”
In a study of an immune therapy for colorectal cancer that involved a single patient, a team of researchers at the National Cancer Institute (NCI) identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene. This targeted immunotherapy led to cancer regression in the patient in the study. … Continue reading “Cellular immunotherapy targets a common human cancer mutation”
President Barack Obama has signed into law legislation that makes new investments in cancer research and battling drug abuse. Obama signed the bill at a ceremony on the White House campus flanked by Vice President Joe Biden and key lawmakers. The 21st Century Cures Act invests $1.8 billion for a cancer research “moonshot” that is … Continue reading “Obama Signs Bill Boosting Spending On Cancer Research”
An experimental prostate cancer therapy could revolutionize treatment. By “shocking” tumors with large amounts of testosterone and then depriving it of the same hormone, doctors from Johns Hopkins University halted the progression of the disease. A man with advanced prostate cancer decided to try an unconventional method, and he’s probably glad he did. Doctors from … Continue reading “Shocking method cures man’s prostate cancer, doctors still ‘figuring out how this works’”